Quick answer: GLP-1 based medical weight loss in Coimbatore is a physician-supervised prescription programme for adults with a BMI of 27.5 or above, or 25 or above with a weight-related condition. Clinical trials show average weight loss of roughly 15 to 20 percent. It requires a clinical assessment to confirm eligibility, medical monitoring throughout, and a maintenance plan to sustain results.
Most people who come to us for weight management have already tried. They have followed diets, lost weight, and watched it return. Some have done this multiple times. They want to understand what is actually different about a physician-supervised programme and whether it makes sense for their situation.
This guide answers those questions directly.
Written and medically reviewed by Dr. Rejeesh Menon, MD, Director, Metabolic Health Program, DermaVue. This article reflects current peer-reviewed evidence and Indian obesity guidelines as of 2026. It is general information, not a substitute for a personal medical consultation.
Why Dieting Alone Usually Does Not Produce Lasting Results
The reason most diets fail long term is not lack of effort. It is biology. When calorie intake drops significantly, the body responds by increasing hunger hormones, reducing fullness signals, and lowering resting metabolism. These changes can persist for at least a year after a diet ends, making sustained weight maintenance through willpower alone very difficult for most people.
For a full explanation of this hormonal response, see our post on why weight comes back after dieting.
GLP-1 based treatment works differently because it directly addresses these hormonal mechanisms rather than relying on the patient to override them through calorie restriction alone.
What GLP-1 Based Treatment Is and How It Works
GLP-1 (glucagon-like peptide-1) is a hormone produced naturally in the gut after eating. It signals fullness to the brain, slows the movement of food through the stomach, and improves the way the body responds to insulin. In people with obesity or overweight, this natural GLP-1 response is often blunted.
GLP-1 receptor agonists are prescription medications that mimic this natural hormone. They produce three effects relevant to weight management:
Reduced hunger. The brain receives stronger and more sustained fullness signals, reducing the drive to eat between meals and making it easier to eat smaller portions without feeling deprived.
Improved insulin response. Better insulin sensitivity means the body stores less fat from carbohydrates and has an easier time accessing stored fat for energy.
Slower gastric emptying. Food moves through the stomach more slowly, extending the feeling of fullness after meals.
These are pharmacological effects that change the hormonal environment. This is why the results of GLP-1 based treatment in clinical trials are significantly better than lifestyle modification alone.
What Results to Expect Realistically
| Treatment approach | Average weight loss at 1 year | Notes |
|---|---|---|
| Lifestyle modification alone | 3 to 5 percent of body weight | Difficult to sustain; hunger increases as weight drops |
| GLP-1 receptor agonist + lifestyle | Approximately 15 percent of body weight | STEP-1 trial, NEJM 2021 |
| Dual-action GLP-1 treatment + lifestyle | Approximately 20 percent of body weight | SURMOUNT-1 trial, NEJM 2022 |
For a 90 kg patient in Coimbatore, 15 percent weight loss means approximately 13.5 kg. For an 80 kg patient, approximately 12 kg. These are average outcomes from large clinical trials with lifestyle support. Individual results vary based on starting weight, adherence, metabolic response, and how well dietary and exercise guidance is followed.
Realistic individual targets are set at the first consultation. No treatment produces the same result for every patient.
Who Is Suitable for the Programme
The programme follows Indian-specific BMI thresholds, which are lower than Western guidelines because South Asian patients carry higher metabolic risk at lower body weights.
Generally suitable:
- Adults with a BMI of 27.5 or above
- Adults with a BMI of 25 or above with at least one weight-related condition: type 2 diabetes or pre-diabetes, PCOS, hypertension, fatty liver disease (NAFLD), obstructive sleep apnoea, or dyslipidaemia
- Patients who have attempted sustained lifestyle changes without adequate results
- Patients whose weight is affecting their quality of life, mobility, or ability to manage a related medical condition
For patients with PCOS-related weight gain, the programme addresses the insulin resistance that drives fat storage in PCOS specifically.
Final eligibility is confirmed only after a full clinical assessment.
Who Is Not Suitable
- Patients who are pregnant, breastfeeding, or planning pregnancy in the near term
- Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2)
- Active pancreatitis or a significant history of pancreatitis
- Severe gastrointestinal conditions such as gastroparesis or active inflammatory bowel disease
- Certain medications that interact with treatment — reviewed at the clinical assessment
- Patients whose primary concern is cosmetic rather than health-related weight management
Some patients are not suitable candidates and are told so clearly at the assessment. There is no obligation to start treatment after attending an assessment.
What the DermaVue Coimbatore Programme Involves
| Stage | What happens | When |
|---|---|---|
| Initial assessment | Full medical history, blood tests (fasting glucose, HbA1c, lipid profile, liver function, thyroid function, full blood count), waist circumference, blood pressure. Eligibility confirmed or declined. Realistic targets set. | Before starting treatment |
| Prescription and initiation | Prescription issued where eligible. Starting dose. Injection technique explained. Dietary protein targets and resistance exercise guidance provided. | Week 1 |
| Dose titration | Dose adjusted based on response and tolerability. Nutritional review. | Weeks 4 to 16 |
| Progress review | Blood tests repeated. Weight, waist, blood pressure checked. Skin and hair assessment if relevant. | 3 months and 6 months |
| Maintenance planning | Discussion of long-term maintenance options. Plan for sustaining results after the initial course. | From month 4 onwards |
Televisit consultations are available for patients in Coimbatore, Tiruppur, Erode, Salem, and Pollachi. All in-person consultations are at our Gandhipuram clinic.
What Happens to Skin and Hair During Weight Loss
Significant weight loss, particularly when rapid, can cause hair fall (telogen effluvium), loose skin, and changes in facial appearance. These are driven by the weight loss itself, not specifically by the medication.
As a dermatology-led programme, DermaVue addresses these concerns proactively: protein targets and resistance exercise guidance are built into the programme to protect muscle and skin, and dermatologist access for hair and skin concerns is available throughout the treatment course.
For a full explanation of these changes and how they are managed, see our post on hair and skin changes on GLP-1 treatment.
The Honest Answer on Stopping Treatment
GLP-1 based treatment does not permanently reset the body’s weight regulation. When treatment is stopped, the hormonal environment shifts back and weight tends to return. On average, roughly two-thirds of weight lost returns within a year of stopping without a maintenance plan.
This is not a reason not to treat. It is the same situation as blood pressure or cholesterol medication: the condition is managed while on treatment, and requires a plan for what happens when treatment ends. Obesity behaves as a chronic, relapsing condition.
DermaVue discusses maintenance from the first consultation. Options include continuing at a lower maintenance dose, a structured lifestyle transition, or a combination approach.
Coimbatore-Specific Considerations
The local diet. The traditional Coimbatore diet is rich in refined carbohydrates, including white rice, idli, dosa, and parota, that produce rapid glucose spikes and drive insulin surges, particularly in patients who are already insulin-resistant. Nutritional guidance in the programme is adapted to Tamil Nadu dietary patterns: switching to red rice or millets at one meal, increasing protein at breakfast, and reducing liquid calories from sweetened tea and coffee.
Physical activity in the heat. Coimbatore’s semi-arid climate makes extended outdoor exercise difficult between 10 am and 6 pm for most of the year. The programme recommends indoor resistance training in the morning or evening, which is more practical and also more effective for muscle preservation than extended outdoor cardio.
Televisit access. For patients in Tiruppur, Erode, Salem, or Pollachi, the full assessment, prescription, and follow-up can be conducted online. Blood tests are arranged at a local laboratory and results reviewed remotely.
How to Get Started
The first step is a clinical assessment at DermaVue Gandhipuram, or a televisit consultation for patients outside Coimbatore city.
| Branch | Address | Phone / WhatsApp |
|---|---|---|
| Coimbatore (Gandhipuram) | 460, Ponnaiyan St, Cross Cut Rd, Ram Nagar, Gandhipuram, Coimbatore, Tamil Nadu 641009 | +91 80868 60018 |
Call +91 80868 60018 or WhatsApp our Coimbatore team to book a consultation.
Related Reading
Dr. Rejeesh Menon, MD — Director, Metabolic Health Program, DermaVue. Dr. Menon is a physician (MD, Internal Medicine) who leads DermaVue’s physician-supervised medical weight management program. This article reflects current peer-reviewed evidence and Indian obesity guidelines as of 2026. It is general information, not a substitute for a personal medical consultation.
